Troy A. Ignelzi

RAPP

Troy A. Ignelzi serves as officer: Chief Financial Officer at Rapport Therapeutics, Inc. Common Stock (RAPP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$244.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$244.5K

Companies Traded

RAPP

Active Period

Mar 2025 – Oct 2026

2 total trades

Most Recent

Buy RAPP

Oct 21, 2026 · $143.6K

Troy A. Ignelzi's Insider Trading at Rapport Therapeutics, Inc. Common Stock (RAPP)

Buys

2 · $244.5K

Sells

0 · $0.00

Total Shares Bought

15,500

Total Shares Sold

RAPP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 21, 2026	Buy	5,500	$26.10	$143.6K	15,500
Mar 13, 2025	Buy	10,000	$10.10	$101.0K	10,000

Related Insiders

HEALY JAMES

director

RAPPBuy · Oct 30, 2026

Abraham Ceesay

director, officer: Chief Executive Officer

RAPPSell · Oct 23, 2026

Ramiro Sanchez

director

RAPPBuy · Oct 23, 2026

Wendy B. Young

director

RAPPBuy · Oct 22, 2026

MARAGANORE JOHN

director

RAPPBuy · Oct 22, 2026

PAUL STEVEN M

director

RAPPBuy · Oct 22, 2026

Paul M Silva

director

RAPPBuy · Oct 22, 2026

Cheryl Gault

officer: Chief Operating Officer

RAPPSell · Oct 1, 2026

Explore More Insider Trading Data

RAPP Insider Trading Activity

View all insider trades at Rapport Therapeutics, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity